Liposomal Doxorubicin: A Review of its Use in Metastatic Breast Cancer and Potential in Non-Hodgkin Lymphoma

Author： Dando Toni M. Keating Gillian M.

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.4, Iss.3, 2005-01, pp. : 193-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy in the Initial Treatment of Newly Diagnosed Cancer Patients: Utilization Trend and Cost Projections for Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, and Metastatic Colorectal Cancer

By Shih Ya-Chen Tina Elting Linda S. Pavluck Alexandre L. Stewart Andrew Halpern Michael T.

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 46-53

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology and etiology of non-Hodgkin lymphoma – a review

By Ekström-Smedby Karin

Acta Oncologica, Vol. 45, Iss. 3, 2006-04 ,pp. : 258-271

Informa Healthcare

Access to resources Recommend Favorite

Non-Hodgkin's lymphoma

By Patte C.

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 359-362

Elsevier

Access to resources Recommend Favorite

Primary malignant nonHodgkin's lymphoma of the breast: A case report

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2597-2600

Spandidos Publications

Access to resources Recommend Favorite

Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

By Alba Emilio Ruiz-Borrego Manuel Margelí Mireia Rodríguez-Lescure Álvaro Sánchez-Rovira Pedro Ruiz Amparo Mel-Lorenzo Jose Ramos-Vázquez Manuel Ribelles Nuria Calvo Elisa Casado Antonio Márquez Antonia Vicente David García-Sáenz José Martín Miguel

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 169-176

Springer Publishing Company

Access to resources Recommend Favorite